Literature DB >> 22080858

The complex interplay between cyclooxygenase-2 and angiotensin II in regulating kidney function.

Torrance Green1, Alexis A Gonzalez, Kenneth D Mitchell, L Gabriel Navar.   

Abstract

PURPOSE OF REVIEW: Cyclooxygenase-2 (COX-2) plays a critical role in modulating deleterious actions of angiotensin II (Ang II) where there is an inappropriate activation of the renin-angiotensin system (RAS). This review discusses the recent developments regarding the complex interactions by which COX-2 modulates the impact of an activated RAS on kidney function and blood pressure. RECENT
FINDINGS: Normal rats with increased COX-2 activity but with different intrarenal Ang II activity because of sodium restriction or chronic treatment with angiotensin-converting enzyme (ACE) inhibitors showed similar renal hemodynamic responses to COX-2-selective inhibition (nimesulide) indicating independence from the intrarenal Ang II activity. COX-2-dependent maintenance of medullary blood flow was consistent and not dependent on dietary salt or ACE inhibition. In contrast, COX-2 influences on sodium excretion were contingent on the prevailing RAS activity. In chronic hypertensive models, COX-2 inhibition elicited similar reductions in kidney function, but COX-2 metabolites contribute to rather than ameliorate the hypertension.
SUMMARY: The maintenance of renal hemodynamics reflects direct and opposing effects of Ang II and COX-2 metabolites. The antagonism in water and electrolyte reabsorption is dependent on the prevailing intrarenal Ang II activity. The recent functional experiments demonstrate a beneficial modulation of Ang II by COX-2 except in the presence of inflammation promoted by hypertension, hyperglycemia, and oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22080858      PMCID: PMC3281505          DOI: 10.1097/MNH.0b013e32834d9d75

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  62 in total

1.  Renal identification of cyclooxygenase-2 in a subset of thick ascending limb cells.

Authors:  C P Vio; C Cespedes; P Gallardo; J L Masferrer
Journal:  Hypertension       Date:  1997-09       Impact factor: 10.190

2.  mPGES-1 deletion impairs aldosterone escape and enhances sodium appetite.

Authors:  Zhanjun Jia; Toshinori Aoyagi; Donald E Kohan; Tianxin Yang
Journal:  Am J Physiol Renal Physiol       Date:  2010-03-24

3.  A maladaptive role for EP4 receptors in podocytes.

Authors:  Erin M Stitt-Cavanagh; Wissam H Faour; Kaede Takami; Anthony Carter; Barbara Vanderhyden; Youfei Guan; Andre Schneider; Matthew D Breyer; Christopher R J Kennedy
Journal:  J Am Soc Nephrol       Date:  2010-07-29       Impact factor: 10.121

4.  Inhibition of cyclooxygenase-2 attenuates urinary prostanoid excretion without affecting renal renin expression.

Authors:  M C Kammerl; R M Nüsing; H W Seyberth; G A Riegger; A Kurtz; B K Krämer
Journal:  Pflugers Arch       Date:  2001-09       Impact factor: 3.657

5.  COX-2 activity determines the level of renin expression but is dispensable for acute upregulation of renin expression in rat kidneys.

Authors:  Corina Matzdorf; A Kurtz; Klaus Höcherl
Journal:  Am J Physiol Renal Physiol       Date:  2007-03-20

6.  Minocycline with aspirin: an approach to attenuate diabetic nephropathy in rats.

Authors:  Lokesh Kumar Bhatt; Veeranjaneyulu Addepalli
Journal:  Ren Fail       Date:  2011       Impact factor: 2.606

7.  Immunohistochemical examination of cyclooxygenase-2 and renin in a KK-A(y) mouse model of diabetic nephropathy.

Authors:  Akira Yabuki; Kazuyuki Taniguchi; Osamu Yamato
Journal:  Exp Anim       Date:  2010

8.  Increased expression of renal cyclooxygenase-2 and neuronal nitric oxide synthase in hypertensive Cx40-deficient mice.

Authors:  Nathalie Krattinger; Florian Alonso; Alessandro Capponi; Lucia Mazzolai; Pascal Nicod; Paolo Meda; Jacques-Antoine Haefliger
Journal:  J Vasc Res       Date:  2008-09-24       Impact factor: 1.934

9.  Selective cyclooxygenase-2 (COX-2) inhibition reduces proteinuria in renal patients.

Authors:  Liffert Vogt; Dick de Zeeuw; Arend Jan J Woittiez; Gerjan Navis
Journal:  Nephrol Dial Transplant       Date:  2008-11-26       Impact factor: 5.992

10.  Role of microsomal prostaglandin E synthase 1 in the kidney.

Authors:  Helene Francois; Carie Facemire; Anil Kumar; Laurent Audoly; Beverly Koller; Thomas Coffman
Journal:  J Am Soc Nephrol       Date:  2007-04-18       Impact factor: 10.121

View more
  10 in total

1.  Enhanced hemodynamic responses to angiotensin II in diabetes are associated with increased expression and activity of AT1 receptors in the afferent arteriole.

Authors:  Jie Zhang; Helena Y Qu; Jiangping Song; Jin Wei; Shan Jiang; Lei Wang; Liqing Wang; Jacentha Buggs; Ruisheng Liu
Journal:  Physiol Genomics       Date:  2017-08-25       Impact factor: 3.107

Review 2.  The Evolving Landscape of Acute Pain Management in the Era of the Opioid Crisis.

Authors:  Ali Pourmand; Gregory Jasani; Courtney Shay; Maryann Mazer-Amirshahi
Journal:  Curr Pain Headache Rep       Date:  2018-08-27

3.  Activation of Nrf2 in Mice Causes Early Microvascular Cyclooxygenase-Dependent Oxidative Stress and Enhanced Contractility.

Authors:  Dan Wang; Cheng Wang; Xueqin Hao; Gabriela Carter; Rafaela Carter; William J Welch; Christopher S Wilcox
Journal:  Antioxidants (Basel)       Date:  2022-04-26

Review 4.  Intrarenal renin-angiotensin system in regulation of glomerular function.

Authors:  L Gabriel Navar
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-01       Impact factor: 2.894

5.  Nonsteroidal anti-inflammatory drugs alter vasa recta diameter via pericytes.

Authors:  Teresa Kennedy-Lydon; Carol Crawford; Scott S Wildman; Claire M Peppiatt-Wildman
Journal:  Am J Physiol Renal Physiol       Date:  2015-07-22

Review 6.  Practical approach to detection and management of acute kidney injury in critically ill patient.

Authors:  Vahid Mohsenin
Journal:  J Intensive Care       Date:  2017-09-16

7.  Association of Nonsteroidal Anti-inflammatory Drug Use With Stroke Among Dialysis Patients.

Authors:  Chih-Cheng Hsu; Yu-Kang Chang; Yueh-Han Hsu; Yu-Ru Lo; Jia-Sin Liu; Chao A Hsiung; Hui-Ju Tsai
Journal:  Kidney Int Rep       Date:  2017-01-17

8.  Impaired ability to modulate glomerular filtration rate in aged female sheep following fetal uninephrectomy.

Authors:  Yugeesh R Lankadeva; Reetu R Singh; Lucinda M Hilliard; Karen M Moritz; Kate M Denton
Journal:  Physiol Rep       Date:  2014-01-28

9.  Antioxidant resveratrol restores renal sodium transport regulation in SHR.

Authors:  Apurva A Javkhedkar; Anees A Banday
Journal:  Physiol Rep       Date:  2015-11-24

Review 10.  Prostaglandins in the pathogenesis of kidney diseases.

Authors:  Yuanyuan Li; Weiwei Xia; Fei Zhao; Zhaoying Wen; Aihua Zhang; Songming Huang; Zhanjun Jia; Yue Zhang
Journal:  Oncotarget       Date:  2018-05-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.